Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | MSCI Europe Health Care 20/35 Capped |
| Investment focus | Equity, Europe, Health Care |
| Fund size | EUR 333 m |
| Total expense ratio | 0.17% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Investment approach | Long-only |
| Sustainability | No |
| Fund currency | EUR |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | 17.01% |
| Inception/ Listing Date | 26 June 2007 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Luxembourg |
| Fund Provider | Xtrackers |
| Fund Structure | Company With Variable Capital (SICAV) |
| UCITS compliance | Yes |
| Administrator | State Street Bank International GmbH, Luxembourg Branch |
| Investment Advisor | DWS Investments UK Limited |
| Custodian Bank | State Street Bank International GmbH, Luxembourg Branch |
| Revision Company | Ernst & Young S.A. |
| Fiscal Year End | 31 December |
| Swiss representative | DWS CH AG |
| Swiss paying agent | Deutsche Bank (Suisse) SA |
| Germany | 30% tax rebate |
| Switzerland | ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | UK Reporting |
| Italy | 26.0% |
| Indextype | Total return index |
| Swap counterparty | Deutsche Bank AG|Barclays Bank PLC|Société Générale|Merrill Lynch International|Goldman Sachs International|BNP Paribas|J.P. Morgan Securities plc|HSBC Bank Plc|Morgan Stanley Capital Services LLC|Citigroup Global Markets Limited |
| Collateral manager | |
| Securities lending | No |
| Securities lending counterparty | UBS AG |
| Roche Holding AG | 15.78% |
| Novartis AG | 15.21% |
| AstraZeneca PLC | 15.02% |
| Novo Nordisk A/S | 8.21% |
| GSK Plc | 5.86% |
| Sanofi | 5.26% |
| EssilorLuxottica SA | 3.40% |
| argenx | 3.11% |
| Lonza Group AG | 2.46% |
| Bayer AG | 2.42% |
| United Kingdom | 23.76% |
| Switzerland | 21.68% |
| France | 9.78% |
| Germany | 6.23% |
| Other | 38.55% |
| Health Care | 65.61% |
| Consumer Discretionary | 3.40% |
| Consumer Staples | 2.23% |
| Other | 28.76% |
| Broker | Rating | Execution fee | Account fee | |
|---|---|---|---|---|
| 0.00 € | 0.00 € | View offer** | |
| 0.00 € | 0.00 € | View offer* | |
| 0.00 € | 0.00 € | View offer* | |
| 0.00 € | 0.00 € | View offer* | |
| 0.00 € | 0.00 € | View offer* |
| Broker | Rating | Order fee | ETF savings plans | |
|---|---|---|---|---|
| 0.00 € | 3550 | View offer** | |
| 0.00 € | 2606 | View offer* | |
| 0.95 € | 2533 | View offer* | |
| 1.00 € | 2624 | View offer* | |
| 0.00 € | 1868 | View offer* |
| YTD | +1.76% |
| 1 month | +3.86% |
| 3 months | +3.35% |
| 6 months | -1.01% |
| 1 year | +15.54% |
| 3 years | +12.84% |
| 5 years | +26.17% |
| Since inception (MAX) | +308.74% |
| 2025 | +4.06% |
| 2024 | +5.09% |
| 2023 | +10.05% |
| 2022 | -5.71% |
| Volatility 1 year | 17.01% |
| Volatility 3 years | 16.37% |
| Volatility 5 years | 15.74% |
| Return per risk 1 year | 0.91 |
| Return per risk 3 years | 0.25 |
| Return per risk 5 years | 0.30 |
| Maximum drawdown 1 year | -12.34% |
| Maximum drawdown 3 years | -27.29% |
| Maximum drawdown 5 years | -27.29% |
| Maximum drawdown since inception | -34.62% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | DXSE | - - | - - | - |
| London Stock Exchange | GBX | XSDR | XSDR LN XSDRINAV | XSDR.L XSDRNAV.DE | |
| Stuttgart Stock Exchange | EUR | DXSE | XSDR GS | XSDR.SG | |
| XETRA | EUR | DXSE | DXSE GY | DXSE.DE |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| iShares MSCI Europe Health Care Sector UCITS ETF EUR (Acc) | 877 | 0.18% p.a. | Accumulating | Full replication |
| State Street SPDR MSCI Europe Health Care UCITS ETF EUR | 595 | 0.18% p.a. | Accumulating | Full replication |